Triple negative breast cancer (TNBC) is characterized by a lack of the expression of progesterone and estrogen receptors and overexpression or amplification of human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.